QOOLABS INC
SAN DIEGO, CA · Medtech · Private
At-home rapid test for hepatitis C virus (HCV) antibody detection from finger prick blood samples
qoolabs.com →- Grants
- $1.1M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $8.8M
- 17 awards · Health and Human S
- #76 of 4531 in medtech
- Patents
- 11
- 0 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Delvpmnt Of A Rapid Test For Hept C Core Antigen | $149,958 | |
| Federal grant | Department of Health and Human Services · Phase I · Lateral Flow Immunoassay POC Device for the Diagnosis of Sickle Cell Disease | $220,578 | |
| Federal contract | Department of Health and Human Services · SBIR Phase II Igf::ot::igf | $718,000 | |
| Federal contract | Department of Health and Human Services · Igf::ct::igf For Critical Functions | $150,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf The Contractor Will Develop Rapid Point Of Care Detection Tests For Serologic Status Of Individuals For Cmv And Hsv Infections. Research Progress Report Will Be Submitted Monthly For Up To A Year. Prototype Tests Will Be Developed For Detection Of Cmv/hsv Serologic Antibody Status. | $225,000 | |
| Federal contract | Department of Health and Human Services · SBIR Phase II Igf::ot::igf | $749,999 | |
| Federal contract | Department of Health and Human Services · SBIR Topic 39 Phase 1- Finding Human Carriers Of Taeniasis To Prevent Neurocysticercosis Epilepsy | $150,000 | |
| Federal contract | Department of Health and Human Services · Contract Award For Topic 388:POINT Of Care Diagnostics For Liver Flukes Opisthorchis Viverrini And Clonorchis Sinensis | $299,991 | |
| Federal contract | Department of Health and Human Services · Affinity Reagents For The Immune System Of Guinea Pigs | $300,000 | |
| Federal contract | Department of Health and Human Services · Affinity Reagents For The Immune System Of Guinea Pigs | $300,000 | |
| Federal contract | Department of Health and Human Services · Point-of-care Hcv Core Antigen Detection | $300,000 | |
| Federal contract | Department of Health and Human Services · Qoolabs, Inc. Will Develop An At-home Rapid Test For Hepatitis C Virus (hcv). | $400,000 | |
| Federal contract· 1 of 2 same day | Department of Health and Human Services · SBIR Topic 107 Monoclonal Antibodies For The Immune Targets Of Swine | $600,000 | |
| Federal contract· 2 of 2 same day | Department of Health and Human Services · SBIR Topic 107 Affinity Reagents For The Immune System Of Golden Hamster | $600,000 | |
| Federal contract | Department of Health and Human Services · SBIR Topic 118: Reagents For Immunologic Analysis Of Non-mammalian And Underrepresented Mammalian Models. | $600,000 | |
| Federal contract | Department of Health and Human Services · SBIR Phase II | $1,500,000 | |
| Federal contract | Department of Health and Human Services · SBIR 133 - Qoolabs | $300,000 | |
| Federal contract | Department of Health and Human Services · Affinity Reagents For The Immune System Of Guinea Pigs IL1B, IL2, IL4, IL6, IL8, IL10, IL12, And IL13. | $1,500,000 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 73 | Rapid Micro Biosystems | $9.3M | $120M |
| 74 | PLATYPUS TECHNOLOGIES LLC | $9.2M | $154K |
| 75 | MESA TECH INTERNATIONAL, INC. | $8.9M | — |
| 76 | QOOLABS INC | $8.8M | — |
| 77 | SCIGLOB INSTRUMENTS & SERVICES LLC | $8.8M | — |
| 78 | MYOMO INC | $8.6M | $6.8M |
| 79 | Keranetics, LLC | $8.4M | $9.9M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Lateral Flow Assay For Assessing Recombinant Protein Expression Or Reporter Gene Expressionapplication
- Camelid Hemoglobin Antibodies And Methods Of Useapplication
- Camelid Single-domain Hcv Antibodies And Methods Of Useapplication
- Camelid Hemoglobin Antibodies And Methods Of Useapplication
- Lateral Flow Assay For Assessing Recombinant Protein Expression Or Reporter Gene Expressionapplication
- Camelid Single-domain Hcv Antibodies And Methods Of Useapplication
- Camelid Hemoglobin Antibodies And Methods Of Useapplication
- Lateral Flow Assay For Assessing Target Conjugationapplication
- Camelid Single-domain Hcv Antibodies And Methods Of Useapplication
- Lateral Flow Assay For Assessing Target Conjugationapplication
- Lateral Flow Assay For Assessing Recombinant Protein Expression Or Reporter Gene Expressionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.